LEADER 04529nam 22012375 450 001 9910136160603321 005 20250416110525.0 035 $a(CKB)3780000000048953 035 $a(MH)014196219-4 035 $a(SSID)ssj0001568459 035 $a(PQKBManifestationID)16214590 035 $a(PQKBTitleCode)TC0001568459 035 $a(PQKBWorkID)14813302 035 $a(PQKB)11558929 035 $a(PPN)193420732 035 $a(FR-PaCSA)88842253 035 $a(FRCYB88842253)88842253 035 $a(EXLCZ)993780000000048953 100 $a20140513d2014 my b 101 0 $afre 135 $aurun| ||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEthique, droit et maladie d'Alzheimer 210 $aParis 210 $cAcademia 210 $d2014 215 $a1 online resource (88 p.) 225 0 $aIntellection âEthique, droit et maladie d'Alzheimer 300 $aAnne Meyer-Heine 330 $aL'ouvrage consiste à aborder les questions éthiques, juridiques et de gouvernance politique impliquées dans la prise en charge des patients atteints de la maladie d'Alzheimer. Cette politique multi niveaux (municipale, départementale, régionale, nationale et européenne) est un des champs d'action publique des plus innovants en matière de politique de santé et un espace d'expérimentation de nouveaux référentiels éthico politiques d'action et d'évaluation. 606 $aAlzheimer's disease$xMoral and ethical aspects 606 $aAlzheimer's disease$xLaw and legislation 606 $aAlzheimer's disease$xPatients$xCare 606 $aAlzheimer Disease 606 $aHealth Policy 606 $aEthics, Medical 606 $aPublic Policy 606 $aTauopathies 606 $aDementia 606 $aEthics, Clinical 606 $aNeurodegenerative Diseases 606 $aNeurocognitive Disorders 606 $aSocial Control Policies 606 $aEthics, Professional 606 $aBrain Diseases 606 $aPolicy 606 $aMental Disorders 606 $aNervous System Diseases 606 $aCentral Nervous System Diseases 606 $aEthics 606 $aSocial Control, Formal 606 $aPsychiatry and Psychology 606 $aDisease 606 $aHumanities 606 $aHealth Care Quality, Access, and Evaluation 606 $aHealth Care Economics and Organizations 606 $aSociology 606 $aSocial Sciences 606 $aAnthropology, Education, Sociology and Social Phenomena 606 $aDelivery of Health Care 606 $aPsychiatric Disorders, Individual$2HILCC 606 $aPsychiatry$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 0$aAlzheimer's disease$xMoral and ethical aspects. 615 0$aAlzheimer's disease$xLaw and legislation. 615 0$aAlzheimer's disease$xPatients$xCare. 615 2$aAlzheimer Disease. 615 2$aHealth Policy. 615 2$aEthics, Medical. 615 2$aPublic Policy. 615 2$aTauopathies. 615 2$aDementia. 615 2$aEthics, Clinical. 615 2$aNeurodegenerative Diseases. 615 2$aNeurocognitive Disorders. 615 2$aSocial Control Policies. 615 2$aEthics, Professional. 615 2$aBrain Diseases. 615 2$aPolicy. 615 2$aMental Disorders. 615 2$aNervous System Diseases. 615 2$aCentral Nervous System Diseases. 615 2$aEthics. 615 2$aSocial Control, Formal. 615 2$aPsychiatry and Psychology 615 2$aDisease. 615 2$aHumanities. 615 2$aHealth Care Quality, Access, and Evaluation. 615 2$aHealth Care Economics and Organizations. 615 2$aSociology. 615 2$aSocial Sciences. 615 2$aAnthropology, Education, Sociology and Social Phenomena 615 2$aDelivery of Health Care. 615 7$aPsychiatric Disorders, Individual 615 7$aPsychiatry 615 7$aHealth & Biological Sciences 700 $aAnne Meyer-Heine$0852740 702 $aMeyer-Heine$b Anne 702 $aMeyer-Heine$b Anne 906 $aBOOK 912 $a9910136160603321 996 $aEthique, droit et maladie d'Alzheimer$91904294 997 $aUNINA 999 $aThis Record contains information from the Harvard Library Bibliographic Dataset, which is provided by the Harvard Library under its Bibliographic Dataset Use Terms and includes data made available by, among others the Library of Congress LEADER 03201nam 22006735 450 001 9910299777603321 005 20250609110116.0 010 $a3-658-09389-7 024 7 $a10.1007/978-3-658-09389-1 035 $a(CKB)3710000000379708 035 $a(EBL)2096049 035 $a(SSID)ssj0001465700 035 $a(PQKBManifestationID)11967644 035 $a(PQKBTitleCode)TC0001465700 035 $a(PQKBWorkID)11487118 035 $a(PQKB)11667201 035 $a(DE-He213)978-3-658-09389-1 035 $a(MiAaPQ)EBC2096049 035 $a(PPN)18489428X 035 $a(MiAaPQ)EBC3109104 035 $a(EXLCZ)993710000000379708 100 $a20150328d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aRisk Estimation on High Frequency Financial Data $eEmpirical Analysis of the DAX 30 /$fby Florian Jacob 205 $a1st ed. 2015. 210 1$aWiesbaden :$cSpringer Fachmedien Wiesbaden :$cImprint: Springer Spektrum,$d2015. 215 $a1 online resource (78 p.) 225 1 $aBestMasters,$x2625-3615 300 $aDescription based upon print version of record. 311 08$a3-658-09388-9 320 $aIncludes bibliographical references. 327 $aMultivariate Standard Normal Tempered Stable Distribution -- FIGARCH -- High Frequency Data and Risk Management. 330 $aBy studying the ability of the Normal Tempered Stable (NTS) model to fit the statistical features of intraday data at a 5 min sampling frequency, Florian Jacobs extends the research on high frequency data as well as the appliance of tempered stable models. He examines the DAX30 returns using ARMA-GARCH NTS, ARMA-GARCH MNTS (Multivariate Normal Tempered Stable) and ARMA-FIGARCH (Fractionally Integrated GARCH) NTS. The models will be benchmarked through their goodness of fit and their VaR and AVaR, as well as in an historical Backtesting. Contents Multivariate Standard Normal Tempered Stable Distribution FIGARCH High Frequency Data and Risk Management Target Groups Researchers and students in the field of finance Practitioners in this area The Author Florian Jacob obtained his Master?s Degree in Business Engineering from the Karlsruhe Institute of Technology focusing on the application of tempered stable distributions on financial data and financial engineering. 410 0$aBestMasters,$x2625-3615 606 $aProbabilities 606 $aMathematics$xData processing 606 $aMathematical analysis 606 $aProbability Theory 606 $aComputational Mathematics and Numerical Analysis 606 $aAnalysis 615 0$aProbabilities. 615 0$aMathematics$xData processing. 615 0$aMathematical analysis. 615 14$aProbability Theory. 615 24$aComputational Mathematics and Numerical Analysis. 615 24$aAnalysis. 676 $a510 676 $a515 676 $a518 676 $a519.2 700 $aJacob$b Florian$4aut$4http://id.loc.gov/vocabulary/relators/aut$0755696 906 $aBOOK 912 $a9910299777603321 996 $aRisk estimation on high frequency financial data$91522850 997 $aUNINA